The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bio-active Peptides Market Research Report 2025
Synopsis
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
The global Bio-active Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bio-active Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio-active Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bio-active Peptides include Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech, Naturade, Royal DSM, MYOS RENS Technology, Natural Factors Nutritional Products and Valio Oy, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio-active Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-active Peptides.
Report Scope
The Bio-active Peptides market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-active Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-active Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Archer Daniels Midland Company
Seagarden AS
Phermpep
Arlak Biotech
Naturade
Royal DSM
MYOS RENS Technology
Natural Factors Nutritional Products
Valio Oy
Wuhan Lullaby Pharmaceutical Chemical
Wuhan Dahua Pharmaceutical
Pharma Foods International
Segment by Type
Natural Bio-active Peptides
Artificial Synthesis Bio-active Peptides
Segment by Application
Food
Health Products
Pharmaceutical
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio-active Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bio-active Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bio-active Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
The global Bio-active Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bio-active Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio-active Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bio-active Peptides include Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech, Naturade, Royal DSM, MYOS RENS Technology, Natural Factors Nutritional Products and Valio Oy, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio-active Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-active Peptides.
Report Scope
The Bio-active Peptides market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-active Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-active Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Archer Daniels Midland Company
Seagarden AS
Phermpep
Arlak Biotech
Naturade
Royal DSM
MYOS RENS Technology
Natural Factors Nutritional Products
Valio Oy
Wuhan Lullaby Pharmaceutical Chemical
Wuhan Dahua Pharmaceutical
Pharma Foods International
Segment by Type
Natural Bio-active Peptides
Artificial Synthesis Bio-active Peptides
Segment by Application
Food
Health Products
Pharmaceutical
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio-active Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bio-active Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bio-active Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Bio-active Peptides Market Overview
1.1 Product Definition
1.2 Bio-active Peptides Segment by Type
1.2.1 Global Bio-active Peptides Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Natural Bio-active Peptides
1.2.3 Artificial Synthesis Bio-active Peptides
1.3 Bio-active Peptides Segment by Application
1.3.1 Global Bio-active Peptides Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Food
1.3.3 Health Products
1.3.4 Pharmaceutical
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Bio-active Peptides Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Bio-active Peptides Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Bio-active Peptides Production Estimates and Forecasts (2019-2030)
1.4.4 Global Bio-active Peptides Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Bio-active Peptides Production Market Share by Manufacturers (2019-2024)
2.2 Global Bio-active Peptides Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Bio-active Peptides, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Bio-active Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Bio-active Peptides Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Bio-active Peptides, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Bio-active Peptides, Product Offered and Application
2.8 Global Key Manufacturers of Bio-active Peptides, Date of Enter into This Industry
2.9 Bio-active Peptides Market Competitive Situation and Trends
2.9.1 Bio-active Peptides Market Concentration Rate
2.9.2 Global 5 and 10 Largest Bio-active Peptides Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Bio-active Peptides Production by Region
3.1 Global Bio-active Peptides Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Bio-active Peptides Production Value by Region (2019-2030)
3.2.1 Global Bio-active Peptides Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Bio-active Peptides by Region (2025-2030)
3.3 Global Bio-active Peptides Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Bio-active Peptides Production by Region (2019-2030)
3.4.1 Global Bio-active Peptides Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Bio-active Peptides by Region (2025-2030)
3.5 Global Bio-active Peptides Market Price Analysis by Region (2019-2024)
3.6 Global Bio-active Peptides Production and Value, Year-over-Year Growth
3.6.1 North America Bio-active Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Bio-active Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Bio-active Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Bio-active Peptides Production Value Estimates and Forecasts (2019-2030)
4 Bio-active Peptides Consumption by Region
4.1 Global Bio-active Peptides Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Bio-active Peptides Consumption by Region (2019-2030)
4.2.1 Global Bio-active Peptides Consumption by Region (2019-2024)
4.2.2 Global Bio-active Peptides Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Bio-active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Bio-active Peptides Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Bio-active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Bio-active Peptides Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Bio-active Peptides Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Bio-active Peptides Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Bio-active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Bio-active Peptides Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Bio-active Peptides Production by Type (2019-2030)
5.1.1 Global Bio-active Peptides Production by Type (2019-2024)
5.1.2 Global Bio-active Peptides Production by Type (2025-2030)
5.1.3 Global Bio-active Peptides Production Market Share by Type (2019-2030)
5.2 Global Bio-active Peptides Production Value by Type (2019-2030)
5.2.1 Global Bio-active Peptides Production Value by Type (2019-2024)
5.2.2 Global Bio-active Peptides Production Value by Type (2025-2030)
5.2.3 Global Bio-active Peptides Production Value Market Share by Type (2019-2030)
5.3 Global Bio-active Peptides Price by Type (2019-2030)
6 Segment by Application
6.1 Global Bio-active Peptides Production by Application (2019-2030)
6.1.1 Global Bio-active Peptides Production by Application (2019-2024)
6.1.2 Global Bio-active Peptides Production by Application (2025-2030)
6.1.3 Global Bio-active Peptides Production Market Share by Application (2019-2030)
6.2 Global Bio-active Peptides Production Value by Application (2019-2030)
6.2.1 Global Bio-active Peptides Production Value by Application (2019-2024)
6.2.2 Global Bio-active Peptides Production Value by Application (2025-2030)
6.2.3 Global Bio-active Peptides Production Value Market Share by Application (2019-2030)
6.3 Global Bio-active Peptides Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Archer Daniels Midland Company
7.1.1 Archer Daniels Midland Company Bio-active Peptides Corporation Information
7.1.2 Archer Daniels Midland Company Bio-active Peptides Product Portfolio
7.1.3 Archer Daniels Midland Company Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Archer Daniels Midland Company Main Business and Markets Served
7.1.5 Archer Daniels Midland Company Recent Developments/Updates
7.2 Seagarden AS
7.2.1 Seagarden AS Bio-active Peptides Corporation Information
7.2.2 Seagarden AS Bio-active Peptides Product Portfolio
7.2.3 Seagarden AS Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Seagarden AS Main Business and Markets Served
7.2.5 Seagarden AS Recent Developments/Updates
7.3 Phermpep
7.3.1 Phermpep Bio-active Peptides Corporation Information
7.3.2 Phermpep Bio-active Peptides Product Portfolio
7.3.3 Phermpep Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Phermpep Main Business and Markets Served
7.3.5 Phermpep Recent Developments/Updates
7.4 Arlak Biotech
7.4.1 Arlak Biotech Bio-active Peptides Corporation Information
7.4.2 Arlak Biotech Bio-active Peptides Product Portfolio
7.4.3 Arlak Biotech Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Arlak Biotech Main Business and Markets Served
7.4.5 Arlak Biotech Recent Developments/Updates
7.5 Naturade
7.5.1 Naturade Bio-active Peptides Corporation Information
7.5.2 Naturade Bio-active Peptides Product Portfolio
7.5.3 Naturade Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Naturade Main Business and Markets Served
7.5.5 Naturade Recent Developments/Updates
7.6 Royal DSM
7.6.1 Royal DSM Bio-active Peptides Corporation Information
7.6.2 Royal DSM Bio-active Peptides Product Portfolio
7.6.3 Royal DSM Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Royal DSM Main Business and Markets Served
7.6.5 Royal DSM Recent Developments/Updates
7.7 MYOS RENS Technology
7.7.1 MYOS RENS Technology Bio-active Peptides Corporation Information
7.7.2 MYOS RENS Technology Bio-active Peptides Product Portfolio
7.7.3 MYOS RENS Technology Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.7.4 MYOS RENS Technology Main Business and Markets Served
7.7.5 MYOS RENS Technology Recent Developments/Updates
7.8 Natural Factors Nutritional Products
7.8.1 Natural Factors Nutritional Products Bio-active Peptides Corporation Information
7.8.2 Natural Factors Nutritional Products Bio-active Peptides Product Portfolio
7.8.3 Natural Factors Nutritional Products Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Natural Factors Nutritional Products Main Business and Markets Served
7.7.5 Natural Factors Nutritional Products Recent Developments/Updates
7.9 Valio Oy
7.9.1 Valio Oy Bio-active Peptides Corporation Information
7.9.2 Valio Oy Bio-active Peptides Product Portfolio
7.9.3 Valio Oy Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Valio Oy Main Business and Markets Served
7.9.5 Valio Oy Recent Developments/Updates
7.10 Wuhan Lullaby Pharmaceutical Chemical
7.10.1 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Corporation Information
7.10.2 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Portfolio
7.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Wuhan Lullaby Pharmaceutical Chemical Main Business and Markets Served
7.10.5 Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
7.11 Wuhan Dahua Pharmaceutical
7.11.1 Wuhan Dahua Pharmaceutical Bio-active Peptides Corporation Information
7.11.2 Wuhan Dahua Pharmaceutical Bio-active Peptides Product Portfolio
7.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Wuhan Dahua Pharmaceutical Main Business and Markets Served
7.11.5 Wuhan Dahua Pharmaceutical Recent Developments/Updates
7.12 Pharma Foods International
7.12.1 Pharma Foods International Bio-active Peptides Corporation Information
7.12.2 Pharma Foods International Bio-active Peptides Product Portfolio
7.12.3 Pharma Foods International Bio-active Peptides Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Pharma Foods International Main Business and Markets Served
7.12.5 Pharma Foods International Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Bio-active Peptides Industry Chain Analysis
8.2 Bio-active Peptides Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Bio-active Peptides Production Mode & Process
8.4 Bio-active Peptides Sales and Marketing
8.4.1 Bio-active Peptides Sales Channels
8.4.2 Bio-active Peptides Distributors
8.5 Bio-active Peptides Customers
9 Bio-active Peptides Market Dynamics
9.1 Bio-active Peptides Industry Trends
9.2 Bio-active Peptides Market Drivers
9.3 Bio-active Peptides Market Challenges
9.4 Bio-active Peptides Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bio-active Peptides Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Bio-active Peptides Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Bio-active Peptides Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Bio-active Peptides Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Bio-active Peptides Production Market Share by Manufacturers (2019-2024)
Table 6. Global Bio-active Peptides Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Bio-active Peptides Production Value Share by Manufacturers (2019-2024)
Table 8. Global Bio-active Peptides Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-active Peptides as of 2023)
Table 10. Global Market Bio-active Peptides Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Bio-active Peptides Production Sites and Area Served
Table 12. Manufacturers Bio-active Peptides Product Types
Table 13. Global Bio-active Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Bio-active Peptides Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Bio-active Peptides Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Bio-active Peptides Production Value Market Share by Region (2019-2024)
Table 18. Global Bio-active Peptides Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Bio-active Peptides Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Bio-active Peptides Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 21. Global Bio-active Peptides Production (Ton) by Region (2019-2024)
Table 22. Global Bio-active Peptides Production Market Share by Region (2019-2024)
Table 23. Global Bio-active Peptides Production (Ton) Forecast by Region (2025-2030)
Table 24. Global Bio-active Peptides Production Market Share Forecast by Region (2025-2030)
Table 25. Global Bio-active Peptides Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Bio-active Peptides Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Bio-active Peptides Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 28. Global Bio-active Peptides Consumption by Region (2019-2024) & (Ton)
Table 29. Global Bio-active Peptides Consumption Market Share by Region (2019-2024)
Table 30. Global Bio-active Peptides Forecasted Consumption by Region (2025-2030) & (Ton)
Table 31. Global Bio-active Peptides Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Bio-active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 33. North America Bio-active Peptides Consumption by Country (2019-2024) & (Ton)
Table 34. North America Bio-active Peptides Consumption by Country (2025-2030) & (Ton)
Table 35. Europe Bio-active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 36. Europe Bio-active Peptides Consumption by Country (2019-2024) & (Ton)
Table 37. Europe Bio-active Peptides Consumption by Country (2025-2030) & (Ton)
Table 38. Asia Pacific Bio-active Peptides Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 39. Asia Pacific Bio-active Peptides Consumption by Region (2019-2024) & (Ton)
Table 40. Asia Pacific Bio-active Peptides Consumption by Region (2025-2030) & (Ton)
Table 41. Latin America, Middle East & Africa Bio-active Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 42. Latin America, Middle East & Africa Bio-active Peptides Consumption by Country (2019-2024) & (Ton)
Table 43. Latin America, Middle East & Africa Bio-active Peptides Consumption by Country (2025-2030) & (Ton)
Table 44. Global Bio-active Peptides Production (Ton) by Type (2019-2024)
Table 45. Global Bio-active Peptides Production (Ton) by Type (2025-2030)
Table 46. Global Bio-active Peptides Production Market Share by Type (2019-2024)
Table 47. Global Bio-active Peptides Production Market Share by Type (2025-2030)
Table 48. Global Bio-active Peptides Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Bio-active Peptides Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Bio-active Peptides Production Value Share by Type (2019-2024)
Table 51. Global Bio-active Peptides Production Value Share by Type (2025-2030)
Table 52. Global Bio-active Peptides Price (US$/Ton) by Type (2019-2024)
Table 53. Global Bio-active Peptides Price (US$/Ton) by Type (2025-2030)
Table 54. Global Bio-active Peptides Production (Ton) by Application (2019-2024)
Table 55. Global Bio-active Peptides Production (Ton) by Application (2025-2030)
Table 56. Global Bio-active Peptides Production Market Share by Application (2019-2024)
Table 57. Global Bio-active Peptides Production Market Share by Application (2025-2030)
Table 58. Global Bio-active Peptides Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Bio-active Peptides Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Bio-active Peptides Production Value Share by Application (2019-2024)
Table 61. Global Bio-active Peptides Production Value Share by Application (2025-2030)
Table 62. Global Bio-active Peptides Price (US$/Ton) by Application (2019-2024)
Table 63. Global Bio-active Peptides Price (US$/Ton) by Application (2025-2030)
Table 64. Archer Daniels Midland Company Bio-active Peptides Corporation Information
Table 65. Archer Daniels Midland Company Specification and Application
Table 66. Archer Daniels Midland Company Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Archer Daniels Midland Company Main Business and Markets Served
Table 68. Archer Daniels Midland Company Recent Developments/Updates
Table 69. Seagarden AS Bio-active Peptides Corporation Information
Table 70. Seagarden AS Specification and Application
Table 71. Seagarden AS Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Seagarden AS Main Business and Markets Served
Table 73. Seagarden AS Recent Developments/Updates
Table 74. Phermpep Bio-active Peptides Corporation Information
Table 75. Phermpep Specification and Application
Table 76. Phermpep Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Phermpep Main Business and Markets Served
Table 78. Phermpep Recent Developments/Updates
Table 79. Arlak Biotech Bio-active Peptides Corporation Information
Table 80. Arlak Biotech Specification and Application
Table 81. Arlak Biotech Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Arlak Biotech Main Business and Markets Served
Table 83. Arlak Biotech Recent Developments/Updates
Table 84. Naturade Bio-active Peptides Corporation Information
Table 85. Naturade Specification and Application
Table 86. Naturade Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Naturade Main Business and Markets Served
Table 88. Naturade Recent Developments/Updates
Table 89. Royal DSM Bio-active Peptides Corporation Information
Table 90. Royal DSM Specification and Application
Table 91. Royal DSM Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Royal DSM Main Business and Markets Served
Table 93. Royal DSM Recent Developments/Updates
Table 94. MYOS RENS Technology Bio-active Peptides Corporation Information
Table 95. MYOS RENS Technology Specification and Application
Table 96. MYOS RENS Technology Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. MYOS RENS Technology Main Business and Markets Served
Table 98. MYOS RENS Technology Recent Developments/Updates
Table 99. Natural Factors Nutritional Products Bio-active Peptides Corporation Information
Table 100. Natural Factors Nutritional Products Specification and Application
Table 101. Natural Factors Nutritional Products Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Natural Factors Nutritional Products Main Business and Markets Served
Table 103. Natural Factors Nutritional Products Recent Developments/Updates
Table 104. Valio Oy Bio-active Peptides Corporation Information
Table 105. Valio Oy Specification and Application
Table 106. Valio Oy Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Valio Oy Main Business and Markets Served
Table 108. Valio Oy Recent Developments/Updates
Table 109. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Corporation Information
Table 110. Wuhan Lullaby Pharmaceutical Chemical Specification and Application
Table 111. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Wuhan Lullaby Pharmaceutical Chemical Main Business and Markets Served
Table 113. Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
Table 114. Wuhan Dahua Pharmaceutical Bio-active Peptides Corporation Information
Table 115. Wuhan Dahua Pharmaceutical Specification and Application
Table 116. Wuhan Dahua Pharmaceutical Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. Wuhan Dahua Pharmaceutical Main Business and Markets Served
Table 118. Wuhan Dahua Pharmaceutical Recent Developments/Updates
Table 119. Pharma Foods International Bio-active Peptides Corporation Information
Table 120. Pharma Foods International Specification and Application
Table 121. Pharma Foods International Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Pharma Foods International Main Business and Markets Served
Table 123. Pharma Foods International Recent Developments/Updates
Table 124. Key Raw Materials Lists
Table 125. Raw Materials Key Suppliers Lists
Table 126. Bio-active Peptides Distributors List
Table 127. Bio-active Peptides Customers List
Table 128. Bio-active Peptides Market Trends
Table 129. Bio-active Peptides Market Drivers
Table 130. Bio-active Peptides Market Challenges
Table 131. Bio-active Peptides Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bio-active Peptides
Figure 2. Global Bio-active Peptides Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Bio-active Peptides Market Share by Type: 2023 VS 2030
Figure 4. Natural Bio-active Peptides Product Picture
Figure 5. Artificial Synthesis Bio-active Peptides Product Picture
Figure 6. Global Bio-active Peptides Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Bio-active Peptides Market Share by Application: 2023 VS 2030
Figure 8. Food
Figure 9. Health Products
Figure 10. Pharmaceutical
Figure 11. Other
Figure 12. Global Bio-active Peptides Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Bio-active Peptides Production Value (US$ Million) & (2019-2030)
Figure 14. Global Bio-active Peptides Production Capacity (Ton) & (2019-2030)
Figure 15. Global Bio-active Peptides Production (Ton) & (2019-2030)
Figure 16. Global Bio-active Peptides Average Price (US$/Ton) & (2019-2030)
Figure 17. Bio-active Peptides Report Years Considered
Figure 18. Bio-active Peptides Production Share by Manufacturers in 2023
Figure 19. Bio-active Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. The Global 5 and 10 Largest Players: Market Share by Bio-active Peptides Revenue in 2023
Figure 21. Global Bio-active Peptides Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Bio-active Peptides Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. Global Bio-active Peptides Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 24. Global Bio-active Peptides Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 25. North America Bio-active Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Europe Bio-active Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. China Bio-active Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Japan Bio-active Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Global Bio-active Peptides Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 30. Global Bio-active Peptides Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 32. North America Bio-active Peptides Consumption Market Share by Country (2019-2030)
Figure 33. Canada Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 34. U.S. Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 35. Europe Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 36. Europe Bio-active Peptides Consumption Market Share by Country (2019-2030)
Figure 37. Germany Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 38. France Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 39. U.K. Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 40. Italy Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 41. Russia Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 42. Asia Pacific Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 43. Asia Pacific Bio-active Peptides Consumption Market Share by Regions (2019-2030)
Figure 44. China Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 45. Japan Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 46. South Korea Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 47. China Taiwan Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 48. Southeast Asia Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 49. India Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 50. Latin America, Middle East & Africa Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 51. Latin America, Middle East & Africa Bio-active Peptides Consumption Market Share by Country (2019-2030)
Figure 52. Mexico Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 53. Brazil Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 54. Turkey Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 55. GCC Countries Bio-active Peptides Consumption and Growth Rate (2019-2024) & (Ton)
Figure 56. Global Production Market Share of Bio-active Peptides by Type (2019-2030)
Figure 57. Global Production Value Market Share of Bio-active Peptides by Type (2019-2030)
Figure 58. Global Bio-active Peptides Price (US$/Ton) by Type (2019-2030)
Figure 59. Global Production Market Share of Bio-active Peptides by Application (2019-2030)
Figure 60. Global Production Value Market Share of Bio-active Peptides by Application (2019-2030)
Figure 61. Global Bio-active Peptides Price (US$/Ton) by Application (2019-2030)
Figure 62. Bio-active Peptides Value Chain
Figure 63. Bio-active Peptides Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
